Skip to main content

Advertisement

Log in

The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

To perform a first meta-analysis on the association between female gender and cancer-specific death risk after radical cystectomy.

Materials and methods

A comprehensive literature search of the MEDLINE and EMBASE databases was conducted for relevant studies published till November 11, 2014. The meta-analysis was performed by estimating the hazard ratios (HRs) and confidence intervals (CIs) through a random-effect approach.

Results

A total of 17 studies were included in the meta-analysis with a total population of 27,912 patients. Female gender was associated with a worse survival outcome (pooled HR 1.20; 95 % CI 1.09–1.32) compared with male gender after radical cystectomy. Subgroup analysis found the correlation was significant in North American and European studies (HR 1.17, 95 % CI 1.02–1.32 and HR 1.34, 95 % CI 1.19–1.51, respectively) and studies from larger size of samples (HR 1.24, 95 % CI 1.11–1.38). We also found studies adjusted for the key elements (T stage, N stage and grade) obtained positive correlation (HR 1.21, 95 % CI 1.09–1.35).

Conclusions

Female demonstrated worse survival outcomes than male after radical cystectomy for bladder cancer. The adoption of more intense cares for female patients was suggested after radical cystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

    Article  PubMed  Google Scholar 

  2. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW et al (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55:876–880

    Article  CAS  PubMed  Google Scholar 

  3. Soave A, Dahlem R, Hansen J, Weisbach L, Minner S et al (2015) Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Eur J Surg Oncol 41:368–377

    Article  CAS  PubMed  Google Scholar 

  4. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241

    Article  PubMed  Google Scholar 

  5. Patel HD, Ball MW, Cohen JE, Kates M, Pierorazio PM et al (2015) Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes. Urology 85:552–560

    Article  PubMed  Google Scholar 

  6. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    Article  PubMed  Google Scholar 

  7. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed Central  PubMed  Google Scholar 

  8. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Otto W, May M, Fritsche HM, Dragun D, Aziz A et al (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9:481–489

    Article  PubMed  Google Scholar 

  10. May M, Burger M, Brookman-May S, Stief CG, Fritsche HM et al (2014) EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. Clin Genitourin Cancer 12:278–286

    Article  PubMed  Google Scholar 

  11. Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M et al (2013) Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol 64:837–845

    Article  PubMed  Google Scholar 

  12. Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y et al (2014) Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology 83:863–867

    Article  PubMed  Google Scholar 

  13. Kluth LA, Rieken M, Xylinas E, Kent M, Rink M et al (2014) Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 66:913–919

    Article  PubMed  Google Scholar 

  14. Moschini M, Suardi N, Pellucchi F, Rocchini L, La Croce G et al (2014) Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma. Anticancer Res 34:3225–3230

    PubMed  Google Scholar 

  15. Da SR, Xylinas E, Kluth L, Crivelli JJ, Chrystal J et al (2013) Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. J Urol 190:487–492

    Article  Google Scholar 

  16. Kwon T, Jeong IG, You D, Hong B, Hong JH et al (2014) Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. J Korean Med Sci 29:669–675

    Article  PubMed Central  PubMed  Google Scholar 

  17. Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL et al (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61:1025–1030

    Article  PubMed Central  PubMed  Google Scholar 

  18. Gore JL, Kwan L, Saigal CS, Litwin MS (2005) Marriage and mortality in bladder carcinoma. Cancer 104:1188–1194

    Article  PubMed  Google Scholar 

  19. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG et al (2014) Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder - development of a tool for clinical decision-making. BJU Int. doi:10.1111/bju.12984

    Google Scholar 

  20. Hermanns T, Bhindi B, Wei Y, Yu J, Noon AP et al (2014) Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer 111:444–451

    Article  CAS  PubMed  Google Scholar 

  21. Kolla SB, Seth A, Singh MK, Gupta NP, Hemal AK et al (2008) Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy. Int Urol Nephrol 40:321–327

    Article  PubMed  Google Scholar 

  22. Fritsche HM, May M, Denzinger S, Otto W, Siegert S et al (2013) Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol 63:739–744

    Article  PubMed  Google Scholar 

  23. Bostrom PJ, Alkhateeb S, Trottier G, Athanasopoulos PZ, Mirtti T et al (2012) Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int 109:70–76

    Article  PubMed  Google Scholar 

  24. Morikawa T, Kawai T, Abe H, Kume H, Homma Y et al (2013) UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy. Int J Clin Exp Pathol 6:1367–1374

    PubMed Central  PubMed  Google Scholar 

  25. Kruger S, Mahnken A, Kausch I, Feller AC (2006) Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma. Urology 67:105–109

    Article  PubMed  Google Scholar 

  26. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241

    Article  PubMed  Google Scholar 

  27. Nieder AM, Lotan Y, Nuss GR, Langston JP, Vyas S et al (2010) Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey. Urol Oncol 28:500–503

    Article  PubMed  Google Scholar 

  28. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120:555–561

    Article  PubMed Central  PubMed  Google Scholar 

  29. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA et al (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116:5235–5242

    Article  PubMed  Google Scholar 

  30. Okajima E, Hiramatsu T, Iriya K, Ijuin M, Matsushima S (1975) Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res 3:73–79

    Article  CAS  PubMed  Google Scholar 

  31. Dietrich K, Demidenko E, Schned A, Zens MS, Heaney J et al (2011) Parity, early menopause and the incidence of bladder cancer in women: a case–control study and meta-analysis. Eur J Cancer 47:592–599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Cantwell MM, Lacey JJ, Schairer C, Schatzkin A, Michaud DS (2006) Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 119:2398–2401

    Article  CAS  PubMed  Google Scholar 

  33. Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I et al (2012) Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 109:1716–1726

    Article  CAS  PubMed  Google Scholar 

  34. Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ et al (2014) Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget 5:7917–7935

    PubMed Central  PubMed  Google Scholar 

  35. Hsu I, Chuang KL, Slavin S, Da J, Lim WX et al (2014) Suppression of ERbeta signaling via ERbeta knockout or antagonist protects against bladder cancer development. Carcinogenesis 35:651–661

    Article  CAS  PubMed  Google Scholar 

  36. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H et al (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99:558–568

    Article  CAS  PubMed  Google Scholar 

  37. Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H (2013) Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog 52:94–102

    Article  PubMed  Google Scholar 

  38. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL et al (2014) Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog 53:314–324

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the study participants, urologists and study coordinators for participating in the study. The study was supported by National Natural Science Foundation of China (Grant No. 81272853).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

The meta-analysis study protocol was approved by the Ethics Committee of Huashan Hospital, Fudan University.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Haowen Jiang or Qiang Ding.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, S., Yang, T., Na, R. et al. The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients. Int Urol Nephrol 47, 951–958 (2015). https://doi.org/10.1007/s11255-015-0980-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-015-0980-6

Keywords

Navigation